PDF
Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council…
The International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…
View Report
Video
The Full Cycle of Psoriasis Care in 2024: Value or Volume? (Webinar 1, 2024 Series).
Dr. Willem Jan Bos highlights the significance of adopting value-based healthcare (#VBHC) to enhance efficiency,…
Watch Video
Event
Global Webinar 1: The Full Cycle of Psoriasis Care in 2024: Value or Volume?.
IPC GLOBAL WEBINAR SERIES
Program chairs: Deepak Balak, Netherlands and Ricardo Romiti, Brazil
Program faculty:…
August 19, 2024
Learn More or Register
Page
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International…
Generalized pustular psoriasis(GPP)lacks internationally accepted definitions and diagnostic criteria, impeding timely…
View Report
Event
IPC & SOLAPSO Symposium: Psoriasis and Infections: A Latin American Prospective.
REUNIÓN ANUAL DE DERMATÓLOGOS LATINOAMERICANOS (RADLA) | LIMA, PERÚ
Tuesday, May 7
09:00– 12:00 PET
Program…
May 7, 2024
Learn More or Register
Blog
A Tribute to IPC Board Member Ricardo Romiti.
During his nine years on the IPC Board, Dr. Ricardo Romiti has shaped the global mission to enhance psoriasis care. As…
Read More
Blog
Focus on Psoriasis: A Report from the 25th World Congress of Dermatology (WCD).
Discover the latest updates on psoriasis from the World Congress of Dermatology (WCD) 2023, hosted in Singapore from…
Read More
Video
A Incapacidade Acumulada no Percurso da Vida de Pacientes com Psoríase.
Dr. Ricardo Romiti discusses CLCI in patients with psoriasis.
El Dr. Ricardo Romiti habla sobre CLCI en pacientes…
Watch Video
Video
Psoriasis in Patients with Cancer or Chronic Infections (Webinar 2, 2023 Series).
This is the second webinar of the IPC Global Webinar Series. It focuses on psoriasis and cancer or chronic infections.
Watch Video
Event
Global Webinar 2: Psoriasis in Patients with Cancer or Chronic Infections.
IPC GLOBAL WEBINAR SERIES
April 18
3:30 pm - 4:30 pm CEST
9:30 am - 10:30 am EDT
Program chair: Lluís Puig,…
April 18, 2023
Learn More or Register
Event
IPC & SOLAPSO Symposium: Advances in the Management of Psoriasis.
REUNIÓN ANUAL DE DERMATÓLOGOS LATINOAMERICANOS (RADLA) | CURITIBA, BRAZIL
Friday, May 26
14:00 – 17:00 BRT
13:00…
May 26, 2023
Learn More or Register
Video
How to Prepare for Another Pandemic (Webinar 5, 2021-2022 Series).
In the final webinar in the series, we will explore lessons from the SARS-CoV-2 pandemic and how we can prepare for…
Watch Video
Video
Infections in Psoriasis Patients Treated with Small Molecules, Biologics, or the Combination (Webinar 5, 2021-2022…
Watch Video
Page
Biosimilars for Psoriasis: Worldwide Overview of Regulatory Guidelines, Uptake and Implications for Dermatology…
The introduction of biological drugs for the treatment of patients with psoriasis has revolutionized treatment…
View Report
Page
Biosimilars for Psoriasis: Clinical Studies to Determine Similarity.
Biosimilars are drugs that are similar, but not identical, to originator biologics. Preclinical analytical studies are…
View Report
Page
Biosimilars in Psoriasis: Clinical Practice and Regulatory Perspectives in Latin America.
Latin American countries view biosimilar agents as an effective approach to curtail health-care expenditures while…
View Report
Page
Biopharmaceuticals and Biosimilars in Psoriasis: What the Dermatologist Needs to Know.
The entry of biosimilar forms of biopharmaceutical therapies for the treatment of psoriasis and other immune-mediated…
View Report
